New Bioinformatics-Based Discrimination Formulas for Differentiation of Thalassemia Traits From Iron Deficiency Anemia

Size: px
Start display at page:

Download "New Bioinformatics-Based Discrimination Formulas for Differentiation of Thalassemia Traits From Iron Deficiency Anemia"

Transcription

1 New Bioinformatics-Based Discrimination Formulas for Differentiation of Thalassemia Traits From Iron Deficiency Anemia Abdul Hafeez Kandhro, MSc, 1,2 Watshara Shoombuatong, PhD, 1 Virapong Prachayasittikul, PhD, 3 Pornlada Nuchnoi, PhD 2,4, * Laboratory Medicine 48:3: ABSTRACT Thalassemia traits (TTs) and iron deficiency anemia (IDA) are the most common disorders of hypochromic microcytic anemia (HMA). The present study aimed to differentiate TTs from IDA by analyzing discrimination formulas and provides comprehensive data of hemoglobin disorders prevalent in Pakistan. Among 12 published discrimination formulas, 6 formulas MI, EF, G&K, RDWI, R, and HHI were the most reliable to discriminate TTs from IDA. The failure cutoff values were improved by the random forest (RF) decision-tree approach. Moreover, the Shine and Lal (S&L) formula, which completely failed to discriminate In clinical practice, HMA is a widespread hematological abnormality that is frequently caused by IDA and hemoglobinopathies (TTs). 1,2 The causes of IDA include inadequate intake of iron, chronic blood loss in the gastrointestinal tract, and, in women, prolonged menstrual bleeding. TTs may result from hereditary defects of one or more globin chains. 2,3 Depending on the type of globin chain defects present, the clinical phenotypes may present as Abbreviations TP, True positive; FP, False positive; FN, False negative; TN, True negative; SN, Sensitivity; SP, Specificity; AUC, Area under curve; ATT, alpha-thalassemia trait; BTT, beta-thalassemia trait; HBE, hemoglobin E; HBS, hemoglobin S; IDA, iron deficiency anemia; TT, thalassemia trait; MI, Mentzer Index; E&F, England & Fraser Index; S&L, Shine and Lal formula; EF, Ehsani formula; SF, Srivastava formula; PP, Palestinian population; G&K, Green & King Index; RDWI, RDW Index; R, Ricerca; HHI, Huber-Herklotz Index. 1 Center of Data Mining & Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand, 2 Center for Research & Innovation Faculty of Medical Technology, Mahidol University, Bangkok, 3 Department of Clinical Microbiology & Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, 4 Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Bangkok IDA from TTs with original cutoff value (<1530), improved with the use of new proposed cutoff value (<1016) and was found to successfully discriminate all cases of TTs from those with IDA. In addition, 2 newly proposed formulas discriminated TTs from IDA more reliably than the original 12 formulas assessed. The proposed formulas could play a crucial role for clinicians to discriminate between TTs and IDA. Keywords: thalassemia trait, iron deficiency anemia, discrimination formula, Pakistan heterozygosity, homozygosity, or double heterozygosity. In addition, co-inheritance of structural hemoglobin variants occurs, such as hemoglobin C, E, or S with TTs. The common co-inheritance forms (hemoglobin E/β-thalassemia and hemoglobin S/β-thalassemia) are present in many countries, including Pakistan, 4-10 India, 11,12 Iran, 13 Turkey 14 and Saudi Arabia. 15,16 Most individuals with TTs, such as α-tt and β-tt, are asymptomatic and have a normal life expectancy. The identification of iron deficiency prior to the development of anemia is difficult. Low mean corpuscular volume (MCV) or low mean cell hemoglobin (MCH) are both indicators for thalassemia. However, these same indicators are found in IDA as well. 17 Hemoglobin electrophoresis used in the identification of α-tt does not provide possible diagnosis, but it is helpful to exclude other microcytic anemias. 18,19 The diagnosis of IDA depends on the serum ferritin level and transferrin saturation level rather than iron staining of bone marrow biopsies. The diagnosis of thalassemia depends on hemoglobin typing and DNA testing. All of these methods require significant expenditures of time and resources to confirm the diagnosis. *To whom correspondence should be addressed. pornlada.nuc@mahidol.ac.th To discriminate between these etiologies of HMA, researchers have proposed formulas based on RBC indices to American Society for Clinical Pathology, All rights reserved. For permissions, please journals.permissions@oup.com 230

2 Table 1. Evaluation of RBC Indices and Standard Discrimination Formula in Differentiation of Thalassemia Traits From IDA According to the Proposed Cutoff Values Along With New Proposed Formulas Cutoff Values RBCs indices / Formulas Standard Cutoff Proposed Cutoff TP FP FN TN SN SP AUC RBC < HB < HCT < MCV < MCH < MCHC < RDW < MI < E&F <0 < S&L <1530 < EF < SF <3.8 < PP <27 < G&K < RDWI < R < HHI < Kerman1 <300 <64.0, <298.0, > Kerman2 <85 >37.0, < Our formula (Kandhro1) < Our formula (Kandhro2) < Formulas (Standard discrimination formulas), Cutoff (Standard / previously published cutoff), TP, True positive; FP, False positive; FN, False negative; TN, True negative; SN, Sensitivity; SP, Specificity; AUC, Area under curve; ATT, alpha-thalassemia trait; BTT, beta-thalassemia trait; HBE, hemoglobin E; HBS, hemoglobin S; IDA, iron deficiency anemia; TT, thalassemia trait; MI, Mentzer Index; E&F, England & Fraser Index; S&L, Shine and Lal formula; EF, Ehsani formula; SF, Srivastava formula; PP, Palestinian population; G&K, Green & King Index; RDWI, RDW Index; R, Ricerca; HHI, Huber-Herklotz Index. differentiate between IDA and TTs. Eight common discrimination formulas are used, such as Mentzer Index (MI), 20 England & Fraser Index (E&F), 21 Shine and Lal formula (S&L), 22 Ehsani formula (EF), 23 Srivastava formula, 24 Palestinian population (PP), 25 Green & King Index (G&K), 26 and RDW Index (RDWI). 27 Existing discrimination formulas vary in sensitivity and specificity, and no single index exists that is suitable for every person. Because these indices were developed in the context of different populations, generations and genders, they may be neither suitable nor easily applied to daily clinical use. Despite multiple mutations in the β-globin gene, a limited number of different mutations account for most of the thalassemia patients in each area. Therefore, the current study aimed to generate a new mathematical formula using a new bioinformatics-based approach, called Random Forest (RF), for accurate discrimination of TTs from IDA in the Pakistani population. RF is nonparametric, interpretable, and efficient and has high prediction accuracy for many types of data. 28 RF-based, new formula cutoff values could be used (a) to reduce the burden of expensive testing for thalassemia, (b) in areas where confirmation by advanced laboratory facilities is lacking, and (c) in high-risk thalassemia areas. Consequently, all the efforts would reduce the carrier rates of α- or /β-tts in the future and with the help of genetic counseling reduce the birth rate of α- or /β-thalassaemia major. Materials and Methods Study Design The retrospective study focused on 3 years ( ) of encoded and unlinked clinical laboratory data obtained from the Healthcare Molecular and Diagnostic Laboratory, Hyderabad, Pakistan. The data consisted of 3030 HMA Lab Medicine 2017;48;

3 Figure 1 Work flow diagram of the study. cases defined as having an MCV <75 fl and an Hb <13 g/dl. The data set included complete blood counts (CBCs) with morphological examination, serum ferritin levels, and Hb electrophoresis. We reviewed the results of the data set and established diagnoses. We classified HMA cases (n=610) into six groups: α-tt (n=7), β-tt (n=300), HBE/β-TT (n=14), HBS/β-TT (n = 15), and IDA/TT (n = 18), and IDA (n = 256) (Table 1). The other 2420 cases had hypothyroidism, anemia of chronic disorders, hepatitis B, C, or D infection, or H. pylori infection and were excluded from the study. The study was conducted under the approval of Mahidol University Central Institutional Review Board (MU-CIRB, COE No. MU-CIRB 2016/ ). Twelve discrimination formulas were evaluated: Mentzer Index (MI), 20 (MCV/RBC); England and Fraser Index (E&F), 21 (MCV RBC- (5 Hb) k); Shine and Lal formula (S&L), 22 (MCV2 MCH/100); Ehsani formula (EF), 23 (MCV 10 RBC); Srivastava formula, 24 (MCH/RBC); Palestinian population (PP), 25 (MCV RBC 3 Hb); Green & King Index (G&K), 26 (MCV2 RDW /(Hb 100)); RDW Index (RDWI), 27 (MCV RDW/RBC); Ricerca (R), 27 (RDW/RBC); Huber-Herklotz Index (HH), 29 ((MCH RDW 0.1/RBC) + RDW); Kerman1, 30 (MCV MCH/RBC); and Kerman2, 30 (KERMAN1 10/MCHC). Figure 1 shows the workflow diagram of present study. Computational Approach Random Forest (RF), based on an ensemble-based decision tree, 28,31 is a widely used ensemble learning method. Breiman and Cutler introduced the RF method to improve prediction performances of classification and regression trees (CART) by growing many weak CART trees. 31 Out-ofbag (OOB) data are used for evaluating feature importance as follows: (a) two-thirds of a training data set is used to construct the predictive classifier and the remainder is used for evaluating the performance of such classifier; and (b) the importance of each feature can be evaluated by measuring the decrease in prediction performance. The performance evaluation can be reported in terms of either accuracy or the Gini index.the proposed cutoffs of our formulas as well as proposed cutoffs of standard formulas were obtained by Random Forest decision tree approach. In addition, the 10-fold cross-validation was applied to training data sets for performance testing. Generation of Proposed Formulas Our data consists of confirmed cases of TT and IDA cases. In Table 1 and Table 2, RBC, MCV, MCH, RDW, and HCT provide higher accuracies. Based on the above parameters, we then manually made various formulas and analyzed 232 Lab Medicine 2017;48; DOI: /labmed/lmx029

4 Table 2. Evaluation of Standard Discrimination Formula in Differentiation of β-thalassemia Trait From IDA According to the Proposed Cutoff Values Along With the New Proposed Formulas' Cutoff Values RBCs indices / Formulas Standard Cutoff Proposed Cutoff TP FP FN TN SN SP AUC RBC < HB < HCT < MCV < MCH < MCHC < RDW < MI < E&F <0 < S&L <1530 < EF < SF <3.8 < PP <27 < G&K < RDWI < R < HHI < Kerman1 <300 <63.7, <298.9, > Kerman2 <85 >37.97, < Kandhro1 < Kandhro2 < Formulas (Standard discrimination formulas), Cutoff (Standard / previously published cutoff), TP, True positive; FP, False positive; FN, False negative; TN, True negative; SN, Sensitivity; SP, Specificity; AUC, Area under curve; ATT, alpha-thalassemia trait; BTT, beta-thalassemia trait; HBE, hemoglobin E; HBS, hemoglobin S; IDA, iron deficiency anemia; TT, thalassemia trait; MI, Mentzer Index; E&F, England & Fraser Index; S&L, Shine and Lal formula; EF, Ehsani formula; SF, Srivastava formula; PP, Palestinian population; G&K, Green & King Index; RDWI, RDW Index; R, Ricerca; HHI, Huber-Herklotz Index. on two types of data; in the first data set, formulas were computed with RBCs indices, while in the second data set, formulas were computed with Hb-electrophoresis, ferritin and confirmed result (Remarks). After more than 10 different possible formulas were tested, 2 were found to provide the best results: (RBC/HCT + 0.5*RDW) and (RDW*5)/RBC. Both those formulas were then analyzed by means of the bioinformatics-based RF decision-tree approach to set the cutoff value for discrimination of TT and IDA. Two sets of cutoff values were obtained for Kandhro-1 and Kandhro-2 formulas: <8.2 and <16.8, respectively. We tested Kandhro-1 and 2 formulas using two different sets of cutoff values with standard formulas. Statistical Analysis We analyzed the data using the Statistical Package for Social Sciences (SPSS) v 18.0 (SPSS Inc, Chicago, IL, USA). One-way analysis of variance (ANOVA) was applied to compare data among the six groups. The sensitivity, specificity, positive and negative predictive values, Mathew correlation coefficient, and area under receiver operative curve (AUROC) were calculated for each formula for comparison of the discriminating formula performance among TT/IDA and β-tt/ida group. A P value of <.05 was defined as statistically significant. Results The baseline characteristics and laboratory data and 12 discriminating formula are summarized in online supplementary Table 1. By using the ANOVA test, significant differences (P <.0001) were observed among the 6 groups in all parameters except age (P =.097). Significant differences also were found in serum ferritin levels among all 6 groups (P <.0001). The accuracies of RBC indices and formulas for discrimination of TTs and IDA with number of cases are illustrated in Table 1. Higher sensitivity and specificity (>95%) and Lab Medicine 2017;48;

5 area under curve (AUC) (1.0) were obtained for both RBC parameters and discrimination formulas. RBC indices (such as RBC, MCV, MCH, and RDW) and discrimination formulas (eg MI, EF, G&K, RDWI, R, and HHI) could distinguish TTs from IDA. However, HB, HCT, and MCHC showed lower specificity (<90%). Their accuracy ranged from 93.22% to for SN and from 12.1% to 76.56% for SP. The E&F, Kerman1, and Kerman2 missed 43, 166, and 166 IDA cases, respectively. In addition, SF, PP, and Kerman2 missed 5, 1, and 131 TT cases, respectively. Thus, SN, SP, and AUC varied greatly, although E&F sensitivity remained 100% (as all TT cases were correctly discriminated from IDA). Very low levels of accuracies were observed in MCHC (12.1% SP and 0.42 AUC). Likewise, very low AUC were observed (Kerman2, 0.38 followed by Kerman1 0.76, respectively). However, the S&L formula completely failed to discriminate IDA cases since all calculated values were below the standard cutoff values (data not shown). RBC indices results are comparable to those of other studies. The mean results of RBC indices in a small study of β-tt and IDA were 5.04 for RBC, HB (10.4), HCT (33.34), MCV (66.82), MCH (20.76), and MCHC (31.08), which is comparable with our results. 32 Ali, et al 33 reported RBC, HB, and MCH values of 5.1, 11.0, and 22.7, respectively, in a small study from Karachi, Pakistan. Another study of 521 subjects with β-tt and IDA reported RBC, MCV, MCH, and RDW values of 5.1, 72.8, 19.9, and 13.9 respectively; only the RBC (5.1) value is comparable to our results. 34 Proposed Formulas In the present study we applied RF approach to generate and test 2 new mathematical formulas for use in the population of Sindh Province, Pakistan. These new formulas were Kandhro1 (RBC/HCT + 0.5*RDW) and Kandhro2 (RDW*5)/ RBC). Analysis of these formulas by the RF, decision tree approach revealed cutoff values with good reliability for discrimination of TTs from IDA. Figure 2 shows the feature importance of the 12 standard formulas and the 2 new proposed formulas. The highest Gini index was found among 11 discrimination formulas, including the 2 proposed formulas, while a lower Gini index was noted in 3 formulas, namely K1, K2, and E&F. From the original data set (n=610), we partitioned data for the RF model as the training data set (n=428). An external data set (n=182) was used for validating the RF model. Analysis of these formulas by the RF decision-tree Figure 2 Standard discrimination formulas (with improved cutoff values) and proposed discrimination formulas. The discrimination formulas feature importance plot shows mean decrease Gini index. The plot shows each discrimination formula on the y-axis, and their importance on the x-axis. The most- to least-important discrimination formulas ordered as top-to-bottom and their importance is given by the position of the dot on the x-axis. Based on mean decrease Gini index, from top-to-bottom as most- to least-important discrimination formulas are SL, HHI, GK, R, RDWI, MI, Kan1, Kan2, E, S, and PP. approach revealed cutoff values that provide good reliability for discrimination of TTs from IDA. The cutoff values of these formulas such as, Kandhro1 < 8.2 and Kandhro2 < 16.8, sample data less than cutoff values indicated TTs, while more than cutoff values indicated IDA The proposed and standard cutoff values of 14 discrimination formulas and the associated parameters are illustrated in Table 1. Eleven discrimination formulas (MI, E&F, S&L, EF, SF, PP, G&K, RDWI, R, HHI, and Kerman1) were found to be the most reliable for differentiating thalassemia traits from IDA, with 100% SN, 100% SP, and 1.0 AUC. Six of the original 12 formulas (MI, EF, PP, G&K, RDWI, and R) exhibited the same SN, SP, and AUC after minor adjusting of cutoff values. Four formulas (E&F, SF, PP, and Kerman1) had improved sensitivities, specificities and AUC. The Kerman2 formula, even with the proposed cutoff values, still did not discriminate TT from IDA. However, these proposed cutoff values did improve the SN, SP, and AUC as compared to standard cutoff values. Interestingly, the 234 Lab Medicine 2017;48; DOI: /labmed/lmx029

6 S&L formula, which failed to discriminate TT from IDA with standard cutoff value (data not shown), successfully discriminated all TT cases from IDA cases with the new proposed cutoff value. The newly proposed formulas, Kandhro1 and Kandhro2, showed 100% accuracy with proposed cutoff values. Similarly, the proposed cutoff values of 12 discrimination formula as compared to standard cutoff values and 2 newly proposed formulas for discrimination between β-tt and IDA are illustrated in Table 2. Comparing Proposed Formulas With Standard Formulas We performed 1-way ANOVA for comparing each proposed formula against competitors and shown in online supplementary Table 2. We found that among 12 discrimination formulas, only 10 (when compared with Kandhro 1) or 11 (when compared with Kandhro 2) formulas are significant in comparison with proposed formulas. This suggested that proposed formulas could be applied in future studies. Cross-Validation The main data set partitioned 2/3 data as a training data set, which is used for analysis of 10-fold cross-validation procedure. We found AUCROC equal 1.0 in 10-fold cross-validation analysis, indicating that Random Forest decision tree approach described here could better classify and discriminate thalassemia traits from IDA Discussion The present study provides comprehensive data on hemoglobin disorders prevalent of Sindh province, Pakistan. A total of 610 HMA cases were enrolled, of whom 256 cases were confirmed to have IDA, 07 to have α-tt, 300 to have β-tt, 14 to have HBE/β-TT, 15 to have HBS/β-TT, and 18 to have IDA/TT. Most of the TTs cases are asymptomatic and, without specialized tests, may be missed or sometimes misdiagnosed as iron deficiency anemia. Since 1970, several researchers have proposed discriminating formulas to differentiate between IDA and TTs. Some common discrimination formulas are MI, 20 E&F, 21 S&L, 22 EF, 23 SF, 24 PP, 25 G&K, 26 and RDWI. 27 Unfortunately, discrimination formulas have varied in sensitivity and specificity, and no single index exists that is suitable for every person. Most of the discrimination formulas were used to differentiation of β-tt and IDA with 100% sensitivity. Therefore, the present study aimed to determine which existing formula could best distinguish TTs from IDA. In addition, we generated new mathematical formulas with a bioinformatics-based approach (ie, RF) for accurate discrimination of TTs from IDA in HMA cases of different ethnic populations of Sindh Province in Pakistan. This study showed that only 6 of the 12 formulas evaluated were reliable in terms of high SN, SP and AUC values. However, the other 6 formulas had statistical values, that varied greatly. The reliability of using these indexes was controversial and varied in many previously published studies from different regions of the world Because these indices developed in the context of different populations, generations and genders, they may be neither suitable nor easily applied to general clinical use. More than 200 mutations have been identified that are involved in impairing transcription, processing or translation of α- or β-globin genes. 38,39 In Pakistan, 16 mutations are commonly recognized, 40 and very recently 5 more have been reported. 40 Niazi et al 41 evaluated 7 discrimination formulas (MI, S&L, SF, E&F, R, G&K, and RDWI) for distinguishing β-tt from IDA. RDWI, MI, and S&L have good discriminative function compared with E&F, G&K, and R. However, none of the formulas are 100% SN and SP. Shen et al 42 evaluated the validity of 12 discrimination indices for differentiation between IDA and β-tt in Chinese children. G&K was the best for differentiation between IDA and β-tt, followed by R, E&F, RDWI, PP, HHI, MI, E, SF, and S&L in decreasing order of performance. In Pakistan, multiple β-globin gene mutations have been identified, although a small number of mutations usually account for most of the thalassemia patients in an area. These mutations affect a certain amount of globin chain synthesis and cause variability in RBC indices. 30 The present study data contained a high number of β-tt cases which are best discriminated from IDA by only 6 discrimination formulas. In one cross-sectional prospective study, different ethnic groups were enrolled over a period of 5 years and their blood samples were analyzed at the DNA level for the 12 most common β-thalassemia mutations in Pakistan. All 12 mutations were found among the different ethnic groups, but prevalence was highest in the Sindhi ethnic group. 43 Although many authors have reported that certain discrimination formulas were reliable for differentiation of IDA from TTs in their Lab Medicine 2017;48;

7 own population, no study has shown whether all these discrimination formulas are valid in other populations. Similarly, remarkable inconsistencies among the 12 discrimination formulas were found in the present study population, and it was not possible to select an ideal discrimination formula with the published standard cutoff values. Therefore, the present study sought to improve the statistical values by applying an RF classification and regression trees (CART) approach and analyzing data for proposed discrimination formula cutoff values that could fit best for our different ethnicities. The proposed cutoff values were obtained by using the R package program and RF decision tree approach. Tables 1 and Table 2 show proposed cutoff values of 12 discrimination formulas as compared to standard cutoff values, along with 2 new proposed formulas and their cutoff values. Nearly all discriminating formulas improved in terms of SN, SP, and AUC when the proposed cutoff values were used. Kerman1 and Kerman2 had showed lower accuracies in standard cutoff values, however, improved with proposed cutoff values. Interestingly, the S&L formula, which completely failed to discriminate IDA with the standard cutoff value (<1530), improved with the proposed cutoff value (<1068), and successfully discriminated all TT cases from IDA. In Pakistan, the remarkable racial mix (due to migrations, invasions, and commercial interactions) represents significant genetic diversity. Consanguineous and close cousin marriage trends, high birth and fertility rates, low educational level, unawareness of trait status before marriages, and lack of public health facilities in remote areas have led Pakistan towards high rates of β-thalassemia carriage. In addition, the scarcity of screening facilities that can perform amniocentesis for DNA analysis during pregnancy and the lack of genetic counseling of positive cases for possible termination of pregnancy have led to a high risk of congenital transmission of β-thalassemia. Therefore, the current study provides new formulas to improve the diagnosis of TT independent of access to high tech methods. Analysis of these proposed formulas by a RF decision tree approach revealed that they could be used with good reliability for discrimination of thalassemia traits from IDA. Further study is necessary to confirm using spectrum of similar diseases and larger sample size. Conclusion Our proposed formulas, with their high sensitivity and specificity, could play a crucial role for clinicians who rely on laboratory results to discriminate between β-tt and other causes of HMA, specifically in premarital screening. Due to the high prevalence of IDA and β-thalassemia traits in many regions of Pakistan, the patient's history of iron intake and a history of thalassemia in a patient s family, along with a CBC, may not be adequate for a firm diagnosis. The proposed formulas provide an additional method to help differentiate IDA from TT. Therefore, the proposed formulas need to be evaluated in future studies of larger population samples. Recommendations There is variation of genetic basis of TTs in each population. The new proposed formulas (Kandhro1 and Kandhro2) along with standard formulas should be further investigated for screening TTs and IDA in high-risk endemic areas using larger population size. Base on our study, MI, EF, G&K, RDWI, R, and HHI are reliable discrimination formulas for ease of use in general population. Red cell indices and discrimination formula, along with clinical findings, should be carefully interpreted to increase the reliable diagnosis of suspected cases. LM Acknowledgments We are grateful for subjects participating in the study. This study was supported by the Faculty of Medical Technology, Mahidol University, Bangkok, and Thailand Research Fund to PN. We sincerely thank Dr. Arthur Brown for language editing and valuable comments on the manuscript. We also acknowledge the following people for their contributions: AHK for collecting and analyzing data as well as the draft of the manuscript; WS and VP for analyzing the data; and PN for formulating research questions, study design, critical comments on the data processing and results as well as revising the manuscript. Our proposed formulas could help to simplify the screening for TTs among high-risk groups in remote areas. They could also be used as a tool in premarital screening of close cousins and in large district or provincial surveys. References 1. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75(5): Lab Medicine 2017;48; DOI: /labmed/lmx029

8 2. Urrechaga E. Red blood cell microcytosis and hypochromia in the differential diagnosis of iron deficiency and beta-thalassaemia trait. Int J Lab Hematol. 2009;31(5): Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am. 2013;60(6): Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge University Press; Population Reference Bureau Lodhi Y. Economics of thalassemia management in Pakistan. Thalassemia awareness week Ansari SH, Shamsi TS, Ashraf M, et al. Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications. Int J Mol Epidemiol Genet. 2011;2(4): Ghani R, Manji MA, Ahmed N. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan. Southeast Asian J Trop Med Public Health. 2002;33(4): Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13(5): Vetter B, Schwarz C, Kohne E, Kulozik AE. Beta-thalassaemia in the immigrant and non-immigrant German populations. Br J Haematol. 1997;97(2): Gribble JN. World Population Data Sheet Washington, DC: Population Reference Bureau Madan N, Sharma S, Sood SK, Colah R, Bhatia LH. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1): Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin. 2008;32(3): Keskin A, Türk T, Polat A, Koyuncu H, Saracoglu B. Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey. Acta Haematol. 2000;104(1): Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6): Wong LP, George E, Tan J-AMA. Public perceptions and attitudes toward thalassaemia: influencing factors in a multi-racial population. BMC Public Health. 2011;11: Rahim F. Microcytic hypochromic anemia patients with thalassemia: genotyping approach. Indian J Med Sci. 2009;63(3): Matos JF, Borges KB, Fernandes APS, Faria JR, Carvalho MDG. RDW as differential parameter between microcytic anemias in pure and concomitant forms. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2015;51(1): Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4): Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808): Hamblin TJ. Differentiation of iron deficiency from thalassemia trait by routine blood-count. Lancet. 1973;1(7804): Shine I, Lal S. A strategy to detect beta-thalassaemia minor. Lancet. 1977;1(8013): Ehsani MA, Shahgholi E, Rahiminejad MS, Seighali F, Rashidi A. A new index for discrimination between iron deficiency anemia and beta-thalassemia minor: results in 284 patients. Pak J Biol Sci. 2009;12(5): Srivastava PC, Bevington JM. Iron deficiency and-or thalassaemia trait. Lancet. 1973;1(7807): Sirdah M, Tarazi I, Al Najjar E, Al Haddad R. Evaluation of the diagnostic reliability of different RBC indices and formulas in the differentiation of the beta-thalassaemia minor from iron deficiency in Palestinian population. Int J Lab Hematol. 2008;30(4): Green R, King R. A new red cell discriminant incorporating volume dispersion for differentiating iron deficiency anemia from thalassemia minor. Blood Cells. 1988;15(3): ; discussion Ricerca BM, Storti S, d Onofrio G, et al. Differentiation of iron deficiency from thalassaemia trait: a new approach. Haematologica. 1987;72(5): Breiman L. Random forests. Mach Learn. 2001;45(1): Huber AR, Ottiger C, Risch L, Regenass S, Hergersberg M, Herklotz R. Thalassämie-Syndrome: Klinik und Diagnose. Syndromes thalassémiques: clinique et diagnostic. Paper presented at: Schweiz Med Forum; Miri-Moghaddam E, Sargolzaie N. Cut off determination of discrimination indices in differential diagnosis between iron deficiency anemia and β- thalassemia minor. Int J Hematol Oncol Stem Cell Res. 2014;8(2): Brieman L, Friedman J, Olshen R, Stone C. Classification and regression trees. Wadsworth & Brooks. Cole Advanced Books & Software; Hussain Z, Malik N, Chughtai A. Diagnostic significance of red cell indices in beta-thalassemia trait. Biomedica. 2005;21: Ali N, Moiz B, Bin Azhar W, Zaidi N, Memon R. Carrier detection for beta-thalassemia trait in general Pakistani population: a way forward. Hematology. 2012;17(4): Qazi RA, Shams R, Hassan H, Asif N. Screening for beta thalassemia trait. Journal of Rawalpindi Medical College (JRMC). 2014;18(1): Nalbantoğlu B, Güzel S, Büyükyalçın V, et al. Indices used in differentiation of thalassemia trait from iron deficiency anemia in pediatric population: are they reliable? Pediatr Hematol Oncol. 2012;29(5): Demir A, Yarali N, Fisgin T, Duru F, Kara A. Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia. Pediatr Int. 2002;44(6): Pornprasert S, Panya A, Punyamung M, Yanola J, Kongpan C. Red cell indices and formulas used in differentiation of β-thalassemia trait from iron deficiency in Thai school children. Hemoglobin. 2014;38(4): Jouini L, Sahli CA, Laaouini N, et al. Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients. Mol Biol Rep. 2013;40(11): Sharma N, Das R, Kaur J, et al. Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major. Eur J Haematol. 2010;84(6): Yasmeen H, Toma S, Killeen N, Hasnain S, Foroni L. The molecular characterization of beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population. Eur J Med Genet. 2016;59(8): Niazi M, Tahir M, e Raziq F, Hameed A. Usefulness of redcell indices in differentiating microcytic hypochromic anemias. Gomal Journal of Medical Sciences. 2010;8(2) Shen C, Jiang YM, Shi H, et al. Evaluation of indices in differentiation between iron deficiency anemia and beta-thalassemia trait for Chinese children. J Pediatr Hematol Oncol. 2010;32(6):e218 e Ansari SH, Baig N, Shamsi TS, et al. Screening immediate family members for carrier identification and counseling: a cost-effective and practical approach. J Pak Med Assoc. 2012;62(12): Lab Medicine 2017;48;

Red Cell Indices and Functions Differentiating Patients with the β-thalassaemia Trait from those with Iron Deficiency Anaemia

Red Cell Indices and Functions Differentiating Patients with the β-thalassaemia Trait from those with Iron Deficiency Anaemia The Journal of International Medical Research 2009; 37: 25 30 [first published online as 37(1) 4] Red Cell Indices and Functions Differentiating Patients with the β-thalassaemia Trait from those with Iron

More information

Superiority of Five Discriminant Indices to Distinguish Thalassemia Trait from Iron Deficiency Anemia

Superiority of Five Discriminant Indices to Distinguish Thalassemia Trait from Iron Deficiency Anemia International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.9, pp 1125-1131, 2017 Superiority of Five Discriminant Indices to Distinguish Thalassemia

More information

Cut off Determination of Discrimination Indices in Differential Diagnosis between Iron Deficiency Anemia and β- Thalassemia Minor

Cut off Determination of Discrimination Indices in Differential Diagnosis between Iron Deficiency Anemia and β- Thalassemia Minor IJHOSCR International Journal of Hematology- Oncology and Stem Cell Research Original Article Cut off Determination of Discrimination Indices in Differential Diagnosis between Iron Deficiency Anemia and

More information

Dr B Lal Clinical Laboratory Pvt Ltd. Jaipur, Rajasthan, India

Dr B Lal Clinical Laboratory Pvt Ltd. Jaipur, Rajasthan, India Volume 1, Issue 1, pp: 1-5 Research Article Introduction Open Access Role of Hematological Indices in the Screening of Β-Thalassemia Minor (Trait) and Iron Deficiency Shaily Garg, Anshika Srivastava, Sanjeev

More information

Use of mathematical indices based on CBC data to identify patients with β thalassemia minor

Use of mathematical indices based on CBC data to identify patients with β thalassemia minor Revista Română de Medicină de Laborator Vol. 8, Nr. 3, Septembrie 27 7 Use of mathematical indices based on CBC data to identify patients with β thalassemia minor Trefor Higgins *, Yann Brierley 2, Annu

More information

Hi & Ha, are new indices in differentiation between Iron deficiency anemia and beta-thalassaemia trait /A Study in Sulaimani City-Kurdistan/Iraq

Hi & Ha, are new indices in differentiation between Iron deficiency anemia and beta-thalassaemia trait /A Study in Sulaimani City-Kurdistan/Iraq IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 7 Ver. I (July. 2015), PP 67-72 www.iosrjournals.org Hi & Ha, are new indices in differentiation

More information

Evaluation of five discriminating indexes to distinguish Beta-Thalassemia Trait from Iron Deficiency Anaemia

Evaluation of five discriminating indexes to distinguish Beta-Thalassemia Trait from Iron Deficiency Anaemia 1627 ORIGINAL ARTICLE Evaluation of five discriminating indexes to distinguish Beta-Thalassemia Trait from Iron Deficiency Anaemia Zahid Ullah, 1 Aamer Ali Khattak, 2 Sara Arif Ali, 3 Javaid Hussain, 4

More information

JMSCR Vol 04 Issue 12 Pages December 2016

JMSCR Vol 04 Issue 12 Pages December 2016 causes of microcytic hypochromic anemia. Sideroblastic anemia and lead intoxication are relatively uncommon. While the diagnosis of beta thalassemia major is usually becomes obvious within initial years

More information

Orignal Article. Neeraja Pethe, Anil Munemane*, Suryakant Dongre ABSTRACT

Orignal Article. Neeraja Pethe, Anil Munemane*, Suryakant Dongre ABSTRACT Orignal Article Determination of Frequency of Thalassaemia Trait in a Rural Tertiary Care Hospital of India by Using Various Red Cell Indices as Screening Tool Neeraja Pethe, Anil Munemane*, Suryakant

More information

BETA THALASSEMIA TRAIT; DIAGNOSTIC IMPORTANCE OF HAEMATOLOGICAL INDICES IN DETECTING BETA THALASSEMIA TRAIT PATIENTS

BETA THALASSEMIA TRAIT; DIAGNOSTIC IMPORTANCE OF HAEMATOLOGICAL INDICES IN DETECTING BETA THALASSEMIA TRAIT PATIENTS The Professional Medical Journal DOI: 10.29309/TPMJ/18.4347 ORIGINAL PROF-4347 BETA THALASSEMIA TRAIT; DIAGNOSTIC IMPORTANCE OF HAEMATOLOGICAL INDICES IN DETECTING BETA THALASSEMIA TRAIT PATIENTS 1. M.Phil

More information

Is Mentzer Index A Reliable Diagnostic Screening Tool For Beta Thalassemia Trait?

Is Mentzer Index A Reliable Diagnostic Screening Tool For Beta Thalassemia Trait? IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 7 Ver. 6 (July. 2018), PP 07-11 www.iosrjournals.org Is Mentzer Index A Reliable Diagnostic

More information

6.1 Extended family screening

6.1 Extended family screening CHAPTER 6 CONCLUSION Cost benefit analysis of thalassemia screening programs have shown that the single years treatment for a β-thalassemia major patient was much higher than a total cost per case prevented.

More information

Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indices

Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indices Original Article Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indices Tahir Jameel 1, Mukhtiar Baig 2, Ijaz Ahmed 3, Muhammad Barakat Hussain 4, Motlag bin Doghaim

More information

Clinical Study Hematological Indices for Differential Diagnosis of Beta Thalassemia Trait and Iron Deficiency Anemia

Clinical Study Hematological Indices for Differential Diagnosis of Beta Thalassemia Trait and Iron Deficiency Anemia Hindawi Publishing Corporation Anemia Volume 2014, Article ID 576738, 7 pages http://dx.doi.org/10.1155/2014/576738 Clinical Study Hematological Indices for Differential Diagnosis of Beta Thalassemia Trait

More information

Validation of new indices for differentiation between iron deficiency anemia and beta thalessemia trait, a study in pregnant females

Validation of new indices for differentiation between iron deficiency anemia and beta thalessemia trait, a study in pregnant females International Journal of Scientific Reports Arora S et al. Int J Sci Rep. 2018 Feb;4(2):26-30 http://www.sci-rep.com pissn 2454-2156 eissn 2454-2164 Original Research Article DOI: http://dx.doi.org/10.18203/issn.2454-2156.intjscirep20180394

More information

UTILITY OF ERYTHROCYTE INDICES FOR SCREENING OF β THALASSEMIA TRAIT IN PREGNANT WOMEN ATTENDING ANTENATAL CLINIC

UTILITY OF ERYTHROCYTE INDICES FOR SCREENING OF β THALASSEMIA TRAIT IN PREGNANT WOMEN ATTENDING ANTENATAL CLINIC UTILITY OF ERYTHROCYTE INDICES FOR SCREENING OF β THALASSEMIA TRAIT IN PREGNANT WOMEN ATTENDING ANTENATAL CLINIC Dr. Ashok Kumar Sharma* 1, Dr. Sudhir Mehta 2, Dr. Shrikant Sharma 3 1 Medical Officer,

More information

The influence of sickle cell and beta thalassaemia traits on type 2 diabetes mellitus

The influence of sickle cell and beta thalassaemia traits on type 2 diabetes mellitus Diabetes Management The influence of sickle cell and beta thalassaemia traits on type 2 diabetes mellitus Taiwo R Kotila *1, Jokotade O Adeleye 2, Mabel A Charles-Davies 3, Funmilola A Mapayi 3, Matthew

More information

Thalassemia in Iran in Last Twenty Years: the Carrier Rates and the Births Trend

Thalassemia in Iran in Last Twenty Years: the Carrier Rates and the Births Trend ORIGINAL ARTICLE IJBC 2013;6(1): 11-18 Thalassemia in Iran in Last Twenty Years: the Carrier Rates and the Births Trend Miri M 1, Tabrizi Namini M 1, Hadipour Dehshal M 1 *, Sadeghian Varnosfaderani F

More information

Report of Beta Thalassemia in Newar Ethnicity

Report of Beta Thalassemia in Newar Ethnicity Report of Beta Thalassemia in Newar Ethnicity Rajendra Dev Bhatt 1*, Surendra Koju 2, Prabodh Risal 1 Affiliations: 1 Department of Clinical Biochemistry, Dhulikhel Hospital, Kathmandu University Hospital

More information

When do you have to perform the molecular biology in the hemoglobinopathies diagnosis

When do you have to perform the molecular biology in the hemoglobinopathies diagnosis When do you have to perform the molecular biology in the hemoglobinopathies diagnosis Maria Domenica Cappellini MD, FRCP;FACP Fondazione Ca Granda Policlinico IRCCS University of Milan Disclosure Member

More information

A Fuzzy-Genetic Approach for Microcytic Anemia Diagnosis in Cyber Medical Systems

A Fuzzy-Genetic Approach for Microcytic Anemia Diagnosis in Cyber Medical Systems Journal of Biomedical Engineering and Technology, 27, Vol. 5, No., 2-9 Available online at http://pubs.sciepub.com/jbet/5//3 Science and Education Publishing DOI:.269/jbet-5--3 A Fuzzy-Genetic Approach

More information

Original Article ABSTRACT. Sanjay Piplani 1 *, Manas Madan 1, Rahul Mannan 1, Mridu Manjari 1, Taranveer Singh 1 and Monika Lalit 2

Original Article ABSTRACT. Sanjay Piplani 1 *, Manas Madan 1, Rahul Mannan 1, Mridu Manjari 1, Taranveer Singh 1 and Monika Lalit 2 Original Article Evaluation of Various Discrimination Indices in Differentiating Iron Deficiency Anemia and Beta Thalassemia Trait: A Practical Low Cost Solution Sanjay Piplani 1 *, Manas Madan 1, Rahul

More information

The pros and cons of the fourth revision of thalassaemia screening programme in Iran

The pros and cons of the fourth revision of thalassaemia screening programme in Iran Original Article The pros and cons of the fourth revision of thalassaemia screening programme in Iran J Med Screen 2017, Vol. 24(1) 1 5! The Author(s) 2016 Reprints and permissions: sagepub.co.uk/journalspermissions.nav

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/35456 holds various files of this Leiden University dissertation. Author: Hassan, Suha Mustafa Title: Toward prevention of Hemoglobinopathies in Oman Issue

More information

Evaluation of M/H Ratio for Screening of B Thalassaemia Trait

Evaluation of M/H Ratio for Screening of B Thalassaemia Trait Evaluation of M/H Ratio for Screening of B Thalassaemia Trait Pages with reference to book, From 84 To 86 Muhammad Saleem, Tanveer Zia Qureshi ( Department Of Haematology, Armed Forces Institute Of Pathology,

More information

MICO Maggio 2016 Laboratory Diagnosis of Thalassemia

MICO Maggio 2016 Laboratory Diagnosis of Thalassemia MICO 11-15 Maggio 2016 Laboratory Diagnosis of Thalassemia Maria Domenica Cappellini Fondazione Ca Granda Policlinico IRCCS University of Milan Disclosure Member of Advisory Board: - Novartis - Genzyme/Sanofi

More information

Proposed low-cost premarital screening program for prevention of sickle cell and thalassemia in Yemen Hafiz Al-Nood 1 Abdulrahman Al-Hadi 2

Proposed low-cost premarital screening program for prevention of sickle cell and thalassemia in Yemen Hafiz Al-Nood 1 Abdulrahman Al-Hadi 2 RESEARCH PAPER Proposed low-cost premarital screening program for prevention of sickle cell and thalassemia in Yemen Hafiz Al-Nood 1 Abdulrahman Al-Hadi 2 ABSTRACT Address for Correspondence: Hafiz Al-Nood

More information

Microcytic Hypochromic Anemia An Approach to Diagnosis

Microcytic Hypochromic Anemia An Approach to Diagnosis Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation

More information

Beta Thalassemia Frequency in Bahrain: A Ten Year Study. Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD*

Beta Thalassemia Frequency in Bahrain: A Ten Year Study. Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD* Bahrain Medical Bulletin, Vol. 2, No. 2, June 200 Beta Thalassemia Frequency in Bahrain: A Ten Year Study Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD* Background: Sickle-cell disease and Thalassanemia

More information

Thalassemias. Emanuela Veras, M.D. 01/08/2006

Thalassemias. Emanuela Veras, M.D. 01/08/2006 Thalassemias Emanuela Veras, M.D. 01/08/2006 Structure and Function of normal Hemoglobin molecules: 2/3 1/3 β: increases from 6 th week of fetal life to 12 months of age At birth: HbF: 75-90% HbA: 10-25%

More information

Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan

Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan HEMATOLOGY RESEARCH ARTICLE Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan Received: 09 March 2016 Accepted: 09 May 2016 First Published: 13 May 2016 *Corresponding

More information

Is NESTROFT better than the hematological indices for screening of betathalassemia trait: an answer in rural scenario

Is NESTROFT better than the hematological indices for screening of betathalassemia trait: an answer in rural scenario Original Research Article DOI: 10.18231/2394-6792.2017.0013 Is NESTROFT better than the hematological indices for screening of betathalassemia trait: an answer in rural scenario Sanjay Piplani 1,*, Manjot

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Alpha Thalassemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_alpha_thalassemia 9/2013 7/2017 7/2018 7/2017 Description

More information

Hematologic Features of Alpha Thalassemia Carriers

Hematologic Features of Alpha Thalassemia Carriers IJMCM Summer 2012, Vol 1, No 3 Original Article Hematologic Features of Alpha Thalassemia Carriers Haleh Akhavan-Niaki 1,2, Reza Youssefi Kamangari 2, Ali Banihashemi 2, Vahid Kholghi Oskooei 1, Mandana

More information

Genetics of Thalassemia

Genetics of Thalassemia Genetics of Thalassemia Submitted by : Raya Samir Al- Hayaly Sura Zuhair Salih Saad Ghassan Al- Dulaimy Saad Farouq Kassir Sama Naal Salouha Zahraa Jasim Al- Aarajy Supervised by : Dr. Kawkab Adris Mahmod

More information

Research Article Coexisting Iron Deficiency Anemia and Beta Thalassemia Trait: Effect of Iron Therapy on Red Cell Parameters and Hemoglobin Subtypes

Research Article Coexisting Iron Deficiency Anemia and Beta Thalassemia Trait: Effect of Iron Therapy on Red Cell Parameters and Hemoglobin Subtypes ISRN Hematology, Article ID 96, pages http://dx.doi.org/.//96 Research Article Coexisting Iron Deficiency Anemia and Beta Thalassemia Trait: Effect of Iron Therapy on Red Cell Parameters and Hemoglobin

More information

Epidemiological Study among Thalassemia Intermedia Pediatric Patients

Epidemiological Study among Thalassemia Intermedia Pediatric Patients Med. J. Cairo Univ., Vol. 78, No. 2, December 651-655, 2010 www.medicaljournalofcairouniversity.com Epidemiological Study among Thalassemia Intermedia Pediatric Patients NERMEEN KADDAH, M.D.; KHALED SALAMA,

More information

1. Introduction. Keywords: Iron Deficiency Anemia, β-thalassemia Trait, Artificial Neural Network, Complete Blood Count, Hemoglobin

1. Introduction. Keywords: Iron Deficiency Anemia, β-thalassemia Trait, Artificial Neural Network, Complete Blood Count, Hemoglobin Journal of Advances in Computer Research Quarterly pissn: 2345-606x eissn: 2345-6078 Sari Branch, Islamic Azad University, Sari, I.R.Iran (Vol. 7, No. 4, November 2016), Pages: 55-66 www.jacr.iausari.ac.ir

More information

Original Paper. Inherited Haemoglobin Disorders Among Apparently Healthy Individuals- An Analysis of 105 Cases. Abstract

Original Paper. Inherited Haemoglobin Disorders Among Apparently Healthy Individuals- An Analysis of 105 Cases. Abstract Original Paper Inherited Haemoglobin Disorders Among Apparently Healthy Individuals- An Analysis of 105 Cases Salsabil MA 1, Islam M 2, Jahan D 3, Khan MA 4 Abstract Introduction: Inherited hemoglobin

More information

USING RETICULOCYTE INDICES TO IDENTIFY α-thalassemia A PRELIMINARY REPORT

USING RETICULOCYTE INDICES TO IDENTIFY α-thalassemia A PRELIMINARY REPORT USING RETICULOCYTE INDICES TO IDENTIFY α-thalassemia A PRELIMINARY REPORT Suphan Soogarun 1, Jamsai Suwansaksri 2 and Viroj Wiwanitkit 3 1 Department of Clinical Microscopy, Faculty of Allied Health Sciences,Chulalongkorn

More information

Diagnostic difficulties in prevention and control program for thalassemia in Thailand: atypical thalassemia carriers

Diagnostic difficulties in prevention and control program for thalassemia in Thailand: atypical thalassemia carriers Diagnostic difficulties in prevention and control program for thalassemia in Thailand: atypical thalassemia carriers Pranee Winichagoon Fucharoen Thalassemia Research Center Institute of Molecular Biosciences

More information

HETEROZYGOUS BETA THALASSEMIA IN PARENTS OF CHILDREN WITH BETA THALASSEMIA MAJOR

HETEROZYGOUS BETA THALASSEMIA IN PARENTS OF CHILDREN WITH BETA THALASSEMIA MAJOR ORIGINAL ARTICLE Heterozygous Beta Thalassemia in Parents of Thalassemics HETEROZYGOUS BETA THALASSEMIA IN PARENTS OF CHILDREN WITH BETA THALASSEMIA MAJOR ABSTRACT Imran-ud-din Khattak 1, Sania Tanweer

More information

S-Beta Thalassemia leading to avascular necrosis of left hip joint in a young male - A rare case report

S-Beta Thalassemia leading to avascular necrosis of left hip joint in a young male - A rare case report Case Report S-Beta Thalassemia leading to avascular necrosis of left hip joint in a young male - A rare case report Shubhi Saxena 1*, Nishant Saxena 1, R.M Jaiswal 2 1 PG Student, 2 Associate Professor,

More information

Frequency Regarding Awareness of Thalassemia amongst the Students, Paramedical Staff and Employees of Tertiary Care Hospital

Frequency Regarding Awareness of Thalassemia amongst the Students, Paramedical Staff and Employees of Tertiary Care Hospital ORIGINAL ARTICLE Frequency Regarding Awareness of Thalassemia amongst the Students, Paramedical Staff and Employees of Tertiary Care Hospital Daniyal Ahmed1, Muhammad Nauman Nawaz1, Kiran Tauseef2, Muhammad

More information

The Beats of Natural Sciences Issue 3-4 (September-December) Vol. 3 (2016)

The Beats of Natural Sciences Issue 3-4 (September-December) Vol. 3 (2016) Frequency of β (Beta Thalassaemia) Trait and Haemaglobin E (HbE) Trait: Case Study in a Thalassaemia Carrier Detection Camp in Gurudas College, West Bengal, India Mitu De Department of Botany, Gurudas

More information

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains Thalassaemias Thalassemia Thalassemia is an inherited autosomal recessive blood disease. Associated with absence or reduction in a or b globin chains. Reduced synthesis of one of the globin chains can

More information

Premarital Screening of Beta Thalassemia Minor in north-east of Iran

Premarital Screening of Beta Thalassemia Minor in north-east of Iran Original Article Premarital Screening of Beta Thalassemia Minor in north-east of Iran Hashemizadeh H MSc 1, Noori R MSc 2 1. Department of Nursing, Quchan Branch, Islamic Azad University, Quchan, Iran.

More information

The Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland

The Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland The Thalassemias in Clinical Practice Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland Outline Thalassemia: definitions and pathophysiology Epidemiology

More information

BLOOD RESEARCH ORIGINAL ARTICLE INTRODUCTION. Pakistan

BLOOD RESEARCH ORIGINAL ARTICLE INTRODUCTION. Pakistan BLOOD RESEARCH VOLUME 50 ㆍ NUMBER 1 March 2015 ORIGINAL ARTICLE Comparative analysis of cellulose acetate hemoglobin electrophoresis and high performance liquid chromatography for quantitative determination

More information

DETECTION OF HETEROZYGOUS BETA THALASSAEMIA IN THE SIBLINGS OF KNOWN BETA THALASSAEMIA MAJOR CHILDREN

DETECTION OF HETEROZYGOUS BETA THALASSAEMIA IN THE SIBLINGS OF KNOWN BETA THALASSAEMIA MAJOR CHILDREN ORIGINAL ARTICLE DETECTION OF HETEROZYGOUS BETA THALASSAEMIA IN THE SIBLINGS OF KNOWN BETA THALASSAEMIA MAJOR CHILDREN Imran-ud-Din Khattak, Mukamil Shah, Sania Tanweer Khattak, Alia Nahid Zaidi, Fazli

More information

Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan,

Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan, Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan, KSA amashi@moh.gov.sa 24/02/2018 β-thalassemia syndromes

More information

Seroprevalence of Sickle Cell Anemia And Thalassemia in Suspected Case of Genetic Disorders in Tribal Predominant Population, Ranchi,India

Seroprevalence of Sickle Cell Anemia And Thalassemia in Suspected Case of Genetic Disorders in Tribal Predominant Population, Ranchi,India IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 3 Ver. X (March. 2017), PP 55-62 www.iosrjournals.org Seroprevalence of Sickle Cell Anemia

More information

Pitfalls in the premarital testing for thalassaemia

Pitfalls in the premarital testing for thalassaemia Pitfalls in the premarital testing for thalassaemia Dr. Riad Amer MB ChB, MSc, FRCP, FRCPath, JBH Assistant Professor of Medicine Al Najah University Consultant Haematologist Case 1 Husband and Wife are

More information

A Reliable Screening Protocol for Thalassemia and Hemoglobinopathies in Pregnancy An Alternative Approach to Electronic Blood Cell Counting

A Reliable Screening Protocol for Thalassemia and Hemoglobinopathies in Pregnancy An Alternative Approach to Electronic Blood Cell Counting Hematopathology / SCREENING FOR THALASSEMIA AND HEMOGLOBINOPATHIES IN PREGNANCY A Reliable Screening Protocol for Thalassemia and Hemoglobinopathies in Pregnancy An Alternative Approach to Electronic Blood

More information

Evaluation of hemoglobinopathy screening results of a six year period in Turkey

Evaluation of hemoglobinopathy screening results of a six year period in Turkey Evaluation of hemoglobinopathy screening results of a six year period in Turkey Seçil Gunher Arıca, Ebru Turhan, Cahit Özer, Vefik Arıca, Dilek Benk Şilfeler, Đbrahim Şilfeler, Ayşe Betül Altun Vol. 4

More information

Anemia s. Troy Lund MSMS PhD MD

Anemia s. Troy Lund MSMS PhD MD Anemia s Troy Lund MSMS PhD MD lundx072@umn.edu Hemoglobinopathy/Anemia IOM take home points. 1. How do we identify the condtion? Smear, CBC Solubility Test (SCD) 2. How does it present clincally? 3. How

More information

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore HAEMATOLOGICAL EVALUATION OF ANEMIA Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore Learning Objectives Laboratory tests for the evaluation of anemia

More information

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Case Report imedpub Journals http://www.imedpub.com Journal of Pediatric Care ISSN 2471-805X DOI: 10.21767/2471-805X.100002 High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Abstract Saudi

More information

Red cell disorder. Dr. Ahmed Hasan

Red cell disorder. Dr. Ahmed Hasan Red cell disorder Dr. Ahmed Hasan Things to be learned in this lecture Definition and clinical feature of anemia. Classification of anemia. Know some details of microcytic anemia Question of the lecture:

More information

JMSCR Vol 06 Issue 01 Page January 2018

JMSCR Vol 06 Issue 01 Page January 2018 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i1.102 HPLC based evaluation of Haemoglobinopathies

More information

Changes to CBC Reference Ranges

Changes to CBC Reference Ranges September 28, 2016 July, 2017 Changes to CBC Reference Ranges At Dynacare, our vision is to be Canada s health and wellness solutions leader. As part of our commitment and continuous efforts to enhance

More information

Jamal I., J. Harmoniz. Res. Med. and Hlth. Sci. 2015, 2(3), PREVALENCE OF BETA-THALASSEMIA TRAIT IN AND AROUND PATNA, BIHAR. Dr.

Jamal I., J. Harmoniz. Res. Med. and Hlth. Sci. 2015, 2(3), PREVALENCE OF BETA-THALASSEMIA TRAIT IN AND AROUND PATNA, BIHAR. Dr. Jamal I., J. Harmoniz. Res. Med. and Hlth. Sci. 2015, 2(3), 68-76 Journal Of Harmonized Research (JOHR) Journal Of Harmonized Research in Medical & Health Sci. 2(3), 2015, 68-76 ISSN 2395 6046 Original

More information

HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS

HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS Hemolytic Anemia Due to Abnormal Hemoglobin Synthesis MODULE 19 HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS 19.1 INTRODUCTION There are two main mechanisms by which anaemia is produced (a) Thalassemia:

More information

Screening for haemoglobinopathies in pregnancy

Screening for haemoglobinopathies in pregnancy Policy Statement All Southern Health patients will receive clinical care that reflects best practice and is based on the best available evidence. Index of chapters within background 1. Prevalence of haemoglobinopathies

More information

Evaluation of Prevalence of Anemia and Its Sociodemographic Correlation among Undergraduate Medical College Students - A Cross Sectional Study

Evaluation of Prevalence of Anemia and Its Sociodemographic Correlation among Undergraduate Medical College Students - A Cross Sectional Study World Journal of Nutrition and Health, 2017, Vol. 5, No. 2, 57-61 Available online at http://pubs.sciepub.com/jnh/5/2/6 Science and Education Publishing DOI:10.12691/jnh-5-2-6 Evaluation of Prevalence

More information

Counselling and prenatal diagnosis. Antonis Kattamis, Greece

Counselling and prenatal diagnosis. Antonis Kattamis, Greece Counselling and prenatal diagnosis Antonis Kattamis, Greece Epidemiology of Hemoglobinopathies 7% of world population carriers of hemoglobinopathies 500.000 newborns annually affected 300.000 : Thalassemias

More information

H aemoglobin A2 can be measured by several laboratory

H aemoglobin A2 can be measured by several laboratory 276 ORIGINAL ARTICLE Some observations on the measurement of haemoglobin A 2 and S percentages by high performance liquid chromatography in the presence and absence of a thalassaemia C E Head, M Conroy,

More information

Thalassemia intermedia in HbH-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis

Thalassemia intermedia in HbH-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis Genes Genet. Syst. (2009) 84, p. 67 71 Thalassemia intermedia in HbH-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis Jin Ai Mary Anne

More information

Thalassemia Maria Luz Uy del Rosario, M.D.

Thalassemia Maria Luz Uy del Rosario, M.D. Thalassemia Maria Luz Uy del Rosario, M.D. Philippine Society of Hematology and Blood Transfusion Philippine Society of Pediatric Oncology What is Thalassemia Hereditary Hemoglobin disorder Hemolytic anemia

More information

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital Case scenarios in Pediatric Hematology and Oncology Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital Objectives * To discuss and learn initial features of childhood leukemia.

More information

Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario A Prospective Cohort Study

Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario A Prospective Cohort Study Hematopathology / PREVALENCE OF THALASSEMIA IN ONTARIO Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario A Prospective Cohort Study John D.

More information

Automated Diagnosis of Thalassemia Based on DataMining Classifiers

Automated Diagnosis of Thalassemia Based on DataMining Classifiers Automated Diagnosis of Thalassemia Based on DataMining Classifiers 1 Eyad H. Elshami, 2 Alaa M. Alhalees Faculty of Information Technology, Islamic University-Gaza, Palestine P.O.Box 108, Rimal, Gaza,

More information

Hematological profile among Sudanese patients with sickle cell anemia

Hematological profile among Sudanese patients with sickle cell anemia EUROPEAN ACADEMIC RESEARCH Vol. III, Issue 4/ July 2015 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Hematological profile among Sudanese patients with sickle cell

More information

Antenatal Detection of Hemoglobinopathies using Red Blood Cells Indices for Screening

Antenatal Detection of Hemoglobinopathies using Red Blood Cells Indices for Screening Sukanya Singh et al. ORIGINAL ARTICLE 10.5005/jp-journals-10054-0064 Antenatal Detection of Hemoglobinopathies using Red Blood Cells Indices for Screening 1 Sukanya Singh, 2 Lalna R Takale, 3 Mona Tilak

More information

Thalassemias:general aspects and molecular pathology

Thalassemias:general aspects and molecular pathology Thalassemias:general aspects and molecular pathology Prof. Renzo Galanello Pediatric Clinic 2 University of Cagliari Ospedale Regionale Microcitemie-ASL8 HEMOGLOBINOPATHIES CLASSIFICATION Structurally

More information

A Prospective & Multicentric Study of RBC Parameters in Patients of Sickle Cell Disorder

A Prospective & Multicentric Study of RBC Parameters in Patients of Sickle Cell Disorder Original Article DOI: 10.21276/APALM.1247 A Prospective & Multicentric Study of RBC Parameters in Patients of Sickle Cell Disorder Prateek Pradeep Umrikar* and Alpesh Prahladpuri Goswami Department of

More information

Research Article Pattern of β-thalassemia and Other Haemoglobinopathies: A Cross-Sectional Study in Bangladesh

Research Article Pattern of β-thalassemia and Other Haemoglobinopathies: A Cross-Sectional Study in Bangladesh International Scholarly Research Network ISRN Hematology Volume 2012, Article ID 659191, 6 pages doi:10.5402/2012/659191 Research Article Pattern of β-thalassemia and Other Haemoglobinopathies: A Cross-Sectional

More information

Line Probe Assay for Detection of Alpha Thalassemia: A Pilot Study

Line Probe Assay for Detection of Alpha Thalassemia: A Pilot Study Line Probe Assay for Detection of Alpha Thalassemia: A Pilot Study Menon PK *, Nimmakayalu M, Bylappa SK, Kumar M, Abdalhaleem HM Center for Advanced Biomedical Research and Innovation, Gulf Medical University,

More information

Thalassemia and other hemoglobinopathies among anemic individuals in Metro Manila: Preliminary findings from the National Nutrition Survey

Thalassemia and other hemoglobinopathies among anemic individuals in Metro Manila: Preliminary findings from the National Nutrition Survey Thalassemia and other hemoglobinopathies among anemic individuals in Metro Manila: Preliminary findings from the National Nutrition Survey Sofia V. Amarra, R.D., Ph.D ILSI Southeast Asia region Definitions

More information

Hematology Unit Lab 1 Review Material

Hematology Unit Lab 1 Review Material Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

Laboratory for diagnosis of THALASSEMIA

Laboratory for diagnosis of THALASSEMIA SCBM343 CLINICAL PATHOLOGY 2(1-2-3) Laboratory for diagnosis of THALASSEMIA PORNTHIP CHAICHOMPOO pornthip.chh@mahidol.ac.th Acknowledgements Dr. Pranee Winichagoon Fucharoen Ms. Pornnapa Khampan Thalassemia

More information

Success of Iran beta thalassemia prevention program:

Success of Iran beta thalassemia prevention program: Success of Iran beta thalassemia prevention program: SUBSTANTIAL REGRESSIVE TREND OF THE INCIDENCE RATE S.S Azimi. PhD in Epidemiology Ministry of health, Genetics Office Thalassaemia prevention programme

More information

Utility of automated RBC parameters in evaluation of anemia

Utility of automated RBC parameters in evaluation of anemia Original article Utility of automated RBC parameters in evaluation of anemia Dr M V Jadhav, Dr Agarwal S A, Dr N V Kadgi, Dr S S Khedkar Dr K K Kulkarni, Dr J.K Kudrimoti Department of Pathology, B J Medical

More information

The LaboratoryMatters

The LaboratoryMatters Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. Complete Blood Count This issue highlights: CBC, while ubiquitous, is an excellent diagnostic

More information

Thalassemia Minor: Routine Erythrocyte Measurements and Differentiation from Iron Deficiency

Thalassemia Minor: Routine Erythrocyte Measurements and Differentiation from Iron Deficiency Thalassemia Minor: Routine Erythrocyte Measurements and Dierentiation rom Iron Deiciency CAGE S. JOHNSON, M.D., CONSTANTINE TEGOS, M.D., AND ERNEST BEUTLER, M.D. The clinical dierentiation o the causes

More information

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital Approach to the child with anemia Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital Definition of anemia Hb< 2 SD or P2.5 below the mean for a healthy of the same gender

More information

BONE MARROW PERIPHERAL BLOOD Erythrocyte

BONE MARROW PERIPHERAL BLOOD Erythrocyte None Disclaimer Objectives Define anemia Classify anemia according to pathogenesis & clinical significance Understand Red cell indices Relate the red cell indices with type of anemia Interpret CBC to approach

More information

KAP STUDY GENETIC DISORDER

KAP STUDY GENETIC DISORDER 50 KAP STUDY GENETIC DISORDER Frequency of carrier screening and preventive orientation among first degree relatives of Thalassaemia patients Seemab Hashim, 1 Mohsin Sarwar, 2 Armish Arsalan, 3 Isma Awan,

More information

Genetic Modulation on the Phenotypic Diversity of Sickle Cell Disease

Genetic Modulation on the Phenotypic Diversity of Sickle Cell Disease Genetic Modulation on the Phenotypic Diversity of Sickle Cell Disease Malay B. Mukherjee Abstract Sickle cell hemoglobin is a β chain structural variant where valine is substituted for glutamic acid in

More information

Spectrum of -thalassemia mutations in Qazvin Province, Iran

Spectrum of -thalassemia mutations in Qazvin Province, Iran African Journal of Biotechnology Vol. x(xx), pp. xxx-xxx, xx xxxxx, 2011 Available online at http://www.academicjournals.org/ajb DOI:xxxxxxxx ISSN 1684 5315 2011 Academic Journals Full Length Research

More information

Current Topics in Hemoglobinopathies

Current Topics in Hemoglobinopathies Current Topics in Hemoglobinopathies Bruce R Haas, MS, LCGC 28-29 September 2015 bruce.r.haas@kp.org 1 How malaria escapes effective immunological responses P falciparum exports PfEMP1 proteins and concentrate

More information

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC Evaluation of Anemia Md. Shafiqul Bari Associate professor (Medicine) SOMC Definition Anemia is operationally defined as a reduction in one or more of the major RBC measurements Hemoglobin concentration

More information

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN DISCUSSION POINTS Importance of hematological immature cell indices Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN Investigate the evidence for clinical utility:

More information

Epidemiology, Care and Prevention of Hemoglobinopathies

Epidemiology, Care and Prevention of Hemoglobinopathies Epidemiology, Care and Prevention of Hemoglobinopathies Nasir Al-Allawi MBChB, PhD. Professor of Hematology College of Medicine University of Dohuk, IRAQ From Research to Practice Training Course in Sexual

More information

Routine screening for a-thalassaemia using an immunochromatographic strip assay for haemoglobin Bart s

Routine screening for a-thalassaemia using an immunochromatographic strip assay for haemoglobin Bart s Original Article Routine screening for a-thalassaemia using an immunochromatographic strip assay for haemoglobin Bart s J Med Screen 2014, Vol. 21(3) 120 125! The Author(s) 2014 Reprints and permissions:

More information

Neonatal Screening for Genetic Blood Diseases. Shaikha Al-Arayyed, PhD* A Aziz Hamza, MD** Bema Sultan*** D. K. Shome, MRCPath**** J. P.

Neonatal Screening for Genetic Blood Diseases. Shaikha Al-Arayyed, PhD* A Aziz Hamza, MD** Bema Sultan*** D. K. Shome, MRCPath**** J. P. Bahrain Medical Bulletin, Vol. 29, No. 3, September, 2007 Neonatal Screening for Genetic Blood Diseases Shaikha Al-Arayyed, PhD* A Aziz Hamza, MD** Bema Sultan*** D. K. Shome, MRCPath**** J. P. Bapat,PhD****

More information

VALIDATION OF OSMOTIC FRAGILITY TEST AND DICHLOROPHENOL INDOPHENOL PRECIPITATION TEST FOR SCREENING OF THALASSEMIA AND Hb E

VALIDATION OF OSMOTIC FRAGILITY TEST AND DICHLOROPHENOL INDOPHENOL PRECIPITATION TEST FOR SCREENING OF THALASSEMIA AND Hb E VALIDATION OF OSMOTIC FRAGILITY TEST AND DICHLOROPHENOL INDOPHENOL PRECIPITATION TEST FOR SCREENING OF THALASSEMIA AND Hb E Siripakorn Sangkitporn 1, Somchai Sangkitporn 1, Areerat Sangnoi 1, Ornchira

More information

Dr.Abdolreza Afrasiabi

Dr.Abdolreza Afrasiabi Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Reaserch Center Shiraz Medical University Hemoglobin tetramer Hemoglobin Structure % A 1 α 2 β 2 94-97% A 2 α 2 δ 2 2.5% A 1C α 2 (β-n-glucose)

More information

PREVALENCE AND CHARACTERIZATION OF THALASSEMIA AMONG MIGRANT WORKERS FROM CAMBODIA, LAO PDR AND MYANMAR IN THAILAND

PREVALENCE AND CHARACTERIZATION OF THALASSEMIA AMONG MIGRANT WORKERS FROM CAMBODIA, LAO PDR AND MYANMAR IN THAILAND PREVALENCE AND CHARACTERIZATION OF THALASSEMIA AMONG MIGRANT WORKERS FROM CAMBODIA, LAO PDR AND MYANMAR IN THAILAND Jitsuda Buakhao 1, Pornnapa Khumpun 2, Pranee Winichagoon 2, Suthat Fucharoen 2 and Kittiphong

More information

The diagnosis of Hemoglobinopathies

The diagnosis of Hemoglobinopathies 1ST IFCC, EFLM, AFCB CONFERENCE "LABORATORY MEDICINE: MEETING THE NEEDS OF MEDITERRANEAN NATIONS" Rome, Italy 02/07/2018 The diagnosis of Hemoglobinopathies Dr Antonino Giambona Unit of Hematology of Rare

More information